recombinant SMAD-7 protein-based therapeutics (University of Colorado Cancer Center)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant SMAD-7 protein-based therapeutics (University of Colorado Cancer Center)
Drug Alias Namerecombinant mothers against decapentaplegic homolog 7 protein-based therapeutics (University of Colorado Cancer Center)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMothers against decapentaplegic homolog 7 stimulants
TargetsMothers against decapentaplegic homolog 7
Therapy Area/IndicationsStomatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado Cancer Center
Active IndicationsN/A
Inactive IndicationsStomatitis

Other Information

ATC CodeN/A
Related LinksN/A